Lawyer, G., A. Altmann, A. Thielen, M. Zazzi, A. Sönnerborg and T. Lengauer: HIV-1 mutational pathways under multidrug therapy. In: AIDS Research and Therapy 8, 1, 1-13, Seq. No.: 26 (2011).
doi: 10.1186/1742-6405-8-26
localid: C125673F004B2D7B-2F93768291824C79C12579810047FA47-Lawyer2011
Prosperi, M.C.F., M. Rosen-Zvi, A. Altmann, M. Zazzi, S. Di Giambenedetto, R. Kaiser, E. Schülter, D. Struck, P. Sloot, D.A. van de Vijver, A.-M. Vandamme and A. Sönnerborg: Antiretroviral Therapy Optimisation without Genotype Resistance Testing: A Perspective on Treatment History Based Models. In: PLoS ONE 5, 10, e13753,1-e13753,8, Seq. No.: e13753 (2010).
doi: 10.1371/journal.pone.0013753
localid: C125673F004B2D7B-059D566EACF3264BC1257823000068C5-Prosperi2010a
Weisser, H., A. Altmann, S. Sierra, F. Incardona, D. Struck, A. Sönnerborg, R. Kaiser, M. Zazzi, M. Tschochner, H. Walter and T. Lengauer: Only Slight Impact of Predicted Replicative Capacity for Therapy Response Prediction. In: Plosone 5, 2, e9044,1-e9044,10, Seq. No.: e9044 (2010).
doi: 10.1371/journal.pone.0009044
localid: C125673F004B2D7B-E4B245D8EE478E3BC12577AE004B419E-Weisser2010a
Altmann, A., M. Rosen-Zvi, M. Prosperi, E. Aharoni, H. Neuvirth, E. Schülter, J. Büch, Y. Peres, I. Incardona, A. Sönnerborg, R. Kaiser, M. Zazzi and T. Lengauer: The EuResist approach for predicting response to anti HIV-1 therapy.
localid: C125756E0038A185-37BB8F81589204E4C1257546004DB142-Altmann2008EDRW
Rosen-Zvi, M., E. Schülter, A. Altmann, S. Sierra-Aragon, M. Zazzi, A. Sönnerborg, M. Oette, T. Lengauer and R. Kaiser: Sustaining lamivudine/emtricitabine, abacavir, zidovudine or atazanavir from a previous treatment shows a clinical benefit.
localid: C125756E0038A185-5013764FF226D126C1257546004D668F-RosenZvi2008IDRW
Altmann, A., T. Sing, H. Vermeiren, B. Winters, E. Van Craenenbroeck, K. Van der Borght, S.-Y. Rhee, R.W. Shafer, E. Schülter, R. Kaiser, Y. Peres, A. Sönnerborg, W.J. Fessel, F. Incardona, M. Zazzi, L. Bacheler, H. Van Vlijmen and T. Lengauer: Advantages of Predicted Phenotypes and Statistical Learning Models in Inferring Virological Response to Antiretroviral Therapy from HIV Genotype. In: Antiviral Therapy 14, 2, 273-283 (2009).
localid: C125673F004B2D7B-EC7EFA9EA38CD0D8C125756000644DA1-Altmann2009AVT
Altmann, A., M. Däumer, N. Beerenwinkel, Y. Peres, E. Schülter, J. Büch, S.-Y. Rhee, A. Sönnerborg, W.J. Fessel, R.W. Shafer, M. Zazzi, R. Kaiser and T. Lengauer: Predicting the Response to Combination Antiretroviral Therapy: Retrospective Validation of geno2pheno-THEO on a Large Clinical Database. In: The Journal of Infectious Diseases 199, 999-1006 (2009).
localid: C125673F004B2D7B-7437741FF0DD8974C125756000639546-Altmann2009JID
Altmann, A., M. Rosen-Zvi, M. Prosperi, E. Aharoni, H. Neuvirth, A. Sönnerborg, E. Schülter, J. Büch, D. Struck, Y. Peres, F. Incardona, R. Kaiser, M. Zazzi and T. Lengauer: Comparison of Classifier Fusion Methods for Predicting Response to Anti HIV-1 Therapy. In: PLoS ONE 3, 10, Seq. No.: e3470 (2008).
doi: 10.1371/journal.pone.0003470
localid: C125756E0038A185-4014325E58E801B4C125750D006D87CB-Altmann2008a
Rosen-Zvi, M., A. Altmann, M. Prosperi, E. Aharoni, H. Neuvirth, A. Sönnerborg, E. Schülter, D. Struck, Y. Peres, F. Incardona, R. Kaiser, M. Zazzi and T. Lengauer: Selecting anti-HIV therapies based on a variety of genomic and clinical factors. In: ISMB 2008 Conference Proceedings, (Eds.) Valencia, Alfonso; Cases, Ildefonso. Bioinformatics. Oxford University Press, Oxford (2008) i399-i406.
doi: 10.1093/bioinformatics/btn141
localid: C125756E0038A185-2B507EB7E868B673C125750D006E9FD1-Rosen2008a
The Max Planck Society does not take any responsibility for the content of this export.